Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 6
2009 13
2010 6
2011 5
2012 12
2013 19
2014 10
2015 22
2016 32
2017 22
2018 18
2019 30
2020 3
Text availability
Article attribute
Article type
Publication date

Search Results

198 results
Results by year
Filters applied: . Clear all
Page 1
Gabapentin for Off-Label Use: Evidence-Based or Cause for Concern?
Peckham AM, et al. Subst Abuse 2018 - Review. PMID 30262984 Free PMC article.
Increasing evidence has emerged suggesting that gabapentin may not be as benign as once thought and may be associated with substance abuse in concert with opioids. ...
Increasing evidence has emerged suggesting that gabapentin may not be as benign as once thought and may be associated with substance abus
Comparison of Quetiapine Abuse and Misuse Reports to the FDA Adverse Event Reporting System With Other Second-Generation Antipsychotics.
Evoy KE, et al. Subst Abuse 2019. PMID 31068753 Free PMC article.
BACKGROUND: Second-generation antipsychotics (SGAs) are assumed to have little abuse potential. However, reports of quetiapine abuse have emerged as prescribing has increased in recent years. ...Although prospective studies are needed to better understand the abuse potential of quetiapine, increased vigilance in monitoring for signs of substance abuse might be warranted when prescribing quetiapine....
BACKGROUND: Second-generation antipsychotics (SGAs) are assumed to have little abuse potential. However, reports of quetiapine abu
198 results
Jump to page
Feedback